Spis treści:
1. REPORT
2. ESAP METADATE
3. INFORMATION ABOUT THE ENTITY
4. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. BGFSC_DATTAD_ESAPS_097900BGGW0000048796-00064_26.rarPreliminary sales revenue data for August 2026

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 279 / 2026
Date of issue: 2026-09-21
Short name of the issuer
SOPHARMA AD
Subject
Preliminary sales revenue data for August 2026
Official market - legal basis
Art. 56 ust. 1 pkt 2 Ustawy o ofercie – informacje bieї№ce i okresowe
Unofficial market - legal basis
Contents of the report:
Sofia, Bulgaria, September 21, 2026 – “Sopharma” AD (SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) pursuant to the requirements of art. 100t of the Law on Public Offering of Securities (LPOS), hereby informs that in August 2026 the Company reported a 1% increase in sales compared to the same month of the previous year, including a 3% decrease in domestic sales and a 4% increase in export sales.
For the period from the beginning of 2026 through the end of August, the Company reported a 43% increase in sales compared to the same period of the previous year, including a 3% increase in domestic sales and an 68% increase in export sales.
Annexes
File Description
BGFSC_DATTAD_ESAPS_097900BGGW0000048796-00064_26.rar
BGFSC_DATTAD_ESAPS_097900BGGW0000048796-00064_26.rar
Preliminary sales revenue data for August 2026

Legal framework Type of information
TRANSD Inside information
RegulatoryData
Collection Body PLKNF
Unique data record identifier
Type of submission New (to be used for new information)
Voluntary information flag
Date or period covered [Date or beginning of the period to which the information relates] 2026-08-01
Date or period covered [Date or end of the period to which the information relates] 2026-08-31
Personal data flag
Macierzyste państwo członkowskie, w stosownych przypadkach PL
DocumentReference
Język, w którym przekazano informacje Oryginał (ORIG) czy tłumaczenie (TRAN) Numer referencyjny pliku danych
PL
ORIG
SubmittingEntity
Submitting entity LEI or Submitting entity name - natural person
RelatedEntity/LegalPerson
Entity LEI Size of the entity Industry sector(s)
097900BGGW0000048796 Large undertaking
(acc. NACE): C

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2026-09-21 Ognian Ivanov Donev Executive Director
20260921_131439_2100244447_BGFSC_DATTAD_ESAPS_097900BGGW0000048796-00064_26.rar